EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Non-allergic Hypersensitivity Reactions to Immunoglobulin Preparations in Antibody Deficiencies: What Role for Anti-IgA IgG and Complement Activation?

Aurore Collet, Diane Pelletier de Chambure, Emmanuelle Moitrot, Gaëlle Breyne, Floriane Mirgot, Stéphanie Rogeau, Mathieu Tronchon, Amélie Nicolas, Sébastien Sanges, Sarah Stabler, Emmanuel Ledoult, Louis Terriou und 5 weitere

Clinical Reviews in Allergy & Immunology · 2024

DOI: 10.1007/s12016-024-09007-0 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Reviews in Allergy & Immunology, 2024. Verfasst von Aurore Collet und 16 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France. aurore.collet@chu-lille.fr. Hauptthemen laut MEDLINE: Complement Activation, Immunoglobulin G. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre Hospitalier Universitaire de Lille.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of IgG anti-IgA in the serum of primary immunodeficiency (PID) patients has long been considered responsible for hypersensitivity (HS) to immunoglobulin preparations (IgPs), but this link is increasingly being questioned. The aim of this work was to describe the prevalence of IgG anti-IgA and its association with HS, and to explore a new pathophysiological hypothesis involving the complement system. We measured IgG anti-IgA, using a standardised commercial technique, in controls and PID patients, and compared our results to a systematic literature review. We measured complement activation in PID patients before and after IgP infusion, and in vitro after incubation of IgP with serum from controls and PID patients. IgG anti-IgA was detected in 6% ( n = 2/32) of PID patients, 30% ( n = 3/10) of selective IgA deficiency patients and 2% ( n = 1/46) of healthy controls. In the literature and our study, 38 PID patients had IgG anti-IgA and HS to IgPs and 9 had IgG anti-IgA but good tolerance to IgPs. In our patients, we observed a constant complement activation after IgP infusion compared to baseline. In vitro, IgP induced significant complement activation with all sera from tested individuals. IgA immunisation is not rare in PID, higher in selective IgA deficiency, but may also occur in healthy controls. Our results question the clinical relevance and pathophysiological implication of IgG anti-IgA in the context of HS with IgPs. Complement activation-related pseudoallergy could explain the clinical characteristics and natural history of HS symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement ActivationImmunoglobulin GHumansFemaleMaleHypersensitivityAdultMiddle AgedImmunologic Deficiency SyndromesChildAdolescentYoung AdultImmunoglobulin AChild, PreschoolAgedAntibodies, Anti-Idiotypic

Stichwörter der Autor:innen

AnaphylaxisAnti-IgA IgGCARPAComplementIntravenous immunoglobulinsPrimary immunodeficiency

Substanzen

Immunoglobulin Ganti-IgAImmunoglobulin AAntibodies, Anti-Idiotypic

Autor:innen und Institutionen

  • Univ. Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France. aurore.collet@chu-lille.fr.
  • INSERM, 59000, Lille, France. aurore.collet@chu-lille.fr.
  • CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, France. aurore.collet@chu-lille.fr.
  • CHU Lille, Service de Pneumologie Et Immuno-Allergologie, Centre de Compétence Maladies Pulmonaires Rares, Lille, France.
  • CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, France.
  • CHU Lille, Département de Médecine Interne Et Immunologie Clinique, Lille, France.

Förderung

  • Centre Hospitalier Universitaire de Lille

Zitieren

APA

Collet, A., de Chambure, D. P., Moitrot, E., Breyne, G., Mirgot, F., Rogeau, S., Tronchon, M., Nicolas, A., Sanges, S., Stabler, S., Ledoult, E., Terriou, L., Launay, D., Hachulla, E., Labalette, M., Dubucquoi, S., & Lefèvre, G. (2024). Non-allergic Hypersensitivity Reactions to Immunoglobulin Preparations in Antibody Deficiencies: What Role for Anti-IgA IgG and Complement Activation?. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-024-09007-0

Vancouver

Collet A, de Chambure DP, Moitrot E, Breyne G, Mirgot F, Rogeau S, et al. Non-allergic Hypersensitivity Reactions to Immunoglobulin Preparations in Antibody Deficiencies: What Role for Anti-IgA IgG and Complement Activation?. Clinical Reviews in Allergy & Immunology. 2024. doi:10.1007/s12016-024-09007-0

BibTeX
@article{Collet2024,
  author = {Collet, Aurore and de Chambure, Diane Pelletier and Moitrot, Emmanuelle and Breyne, Gaëlle and Mirgot, Floriane and Rogeau, Stéphanie and Tronchon, Mathieu and Nicolas, Amélie and Sanges, Sébastien and Stabler, Sarah and Ledoult, Emmanuel and Terriou, Louis and Launay, David and Hachulla, Eric and Labalette, Myriam and Dubucquoi, Sylvain and Lefèvre, Guillaume},
  title = {Non-allergic Hypersensitivity Reactions to Immunoglobulin Preparations in Antibody Deficiencies: What Role for Anti-IgA IgG and Complement Activation?},
  journal = {Clinical Reviews in Allergy & Immunology},
  year = {2024},
  doi = {10.1007/s12016-024-09007-0}
}
Kostenlos starten →